SION
Sionna Therapeutics Earnings
$43.49
Earnings Summary
Revenue | $0Mn |
Net Profits | $-20.44Mn |
Net Profit Margins | -Inf% |
Sionna Therapeutics’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Sionna Therapeutics has generated NaN% jump in its revenue since last 3-months.
Sionna Therapeutics’s net profit fell -28.98% since last year same period to $-20.44Mn in the Q4 2025. On a quarterly growth basis, Sionna Therapeutics has generated -0.8% fall in its net profits since last 3-months.
Sionna Therapeutics’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Sionna Therapeutics has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.71 |
EPS Estimate Current Year | -0.71 |
Sionna Therapeutics’s earning per share (EPS) estimates for the current quarter stand at -0.71 - a -18.33% fall from last quarter’s estimates.
Sionna Therapeutics’s earning per share (EPS) estimates for the current year stand at -0.71.
Key Ratios
Earning Per Share (EPS) | -0.46 |
Sionna Therapeutics’s earning per share (EPS) jumped 86.39% since last year same period to -0.46 in the Q4 2025. This indicates that the Sionna Therapeutics has generated 86.39% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-05 | -0.6 | -0.46 | 23.33% |
2026-03-02 | -0.71 | -0.46 | 35.21% |
2025-08-11 | -0.52 | -0.41 | 21.15% |
2025-03-31 | -0.45 | -0.62 | -37.78% |
